Error: Could not add to watchlist. X
+ Watchlist

Cephalon Inc

CEPH:US
Acquired
CEPH:US was acquired by TEVA:IT
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
8.55
Market Cap (USD)
-
Shares Outstanding (m)
77.938
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Cephalon Inc. provides biopharmaceutical products. The Company develops and markets medicines for the treatment of central nervous system disorders, cancer, and pain management. Cephalon serves customers worldwide.
Address
41 Moores Road
Malvern, PA 19355
United States
Phone
1-610-344-0200
Show More